Prompt
Are there any small-molecule API CDMO providers that focus on tech transfer support for late-stage development?
Latest observation
Sep 17, 2026
OpenAI APIWeb search: off
Yes. A number of small-molecule API CDMOs explicitly position themselves around tech transfer support for late-stage development, process scale-up, and commercial readiness rather than only early discovery work.
Examples of providers you might look at:
- CordenPharma — offers late-stage process development, tech transfer, and GMP API manufacturing.
- Lonza — strong in process development and tech transfer for clinical to commercial small-molecule APIs.
- Cambrex — known for API development and manufacturing with support for late-stage development and tech transfer.
- WuXi STA — broad small-molecule API development/manufacturing with tech transfer and scale-up capabilities.
- Farmabios / Minakem / Siegfried / Piramal Pharma Solutions — each has capabilities spanning process development, transfer, and GMP/API scale-up.
- Almac Sciences — provides integrated process development and tech transfer support for APIs and intermediates.
- Curia — offers API development and manufacturing services, including tech transfer and late-phase support.
What to look for in a provider if your focus is late-stage tech transfer:
- documented process transfer experience from another site or sponsor
- late-phase / Phase IIb-III and commercial API capability
- strong analytical method transfer and validation support
- impurity control, route optimization, and robustness studies
- cGMP manufacturing with regulatory filing support
- experience with contained potent APIs, if relevant
If you want, I can also give you:
- a shortlist by geography (US/EU/Asia),
- a comparison table, or
- a list specifically for high-potency APIs or orally solid dosage-linked API transfers.